Psychedelics in palliative care
from Scientific American
The FDA has given MDMA, also known as ecstasy or molly, designation as a breakthrough therapy. It is also in phase III of its clinical trials, the last phase before going to market as a prescription. Colloquially, providers refer to psilocybin as magic mushrooms. New research is confirming its potency by showing that cancer patients treated just once with psilocybin experienced treatment benefits present five years later. For those with anxiety in the face of a new illness diagnosis, treatment with psychedelic medicine provided relief from anxiety, allowing patients the capacity to engage with their medical care with more presence and purpose.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063